Januvia Pancreatic Cancer Lawsuit To Be Decided By Jury, Illinois Appeals Court Determines
An Illinois appeals court has reinstated two Januvia lawsuits, saying that juries must decide failure to warn claims over pancreatic cancer risks.…
«
»
An Illinois appeals court has reinstated two Januvia lawsuits, saying that juries must decide failure to warn claims over pancreatic cancer risks.…
A growing number of lawsuits over claims that Byetta, Victoza and similar diabetes drugs can cause pancreatic cancer are being filed in the wake of a recent decision to reinstate the litigation.…
A new schedule for Byetta, Januvia and Victoza pancreatic cancer lawsuits sets the first bellwether trial for January 2020.…
More than 700 Victoza, Byetta, Januvia and Janumet pancreatic cancer lawsuits have been reinstated by a federal appeals court, overturning a summary judgment that led to their dismissal in 2015.…
A federal judge has granted summary judgment in the federal litigation over incretin mimetic diabetes drugs, which alleged that inadequate warnings were provided about the risk of pancreatic cancer from Byetta, Victoza, Januvia and Janumet.…
Doctors should individualize diabetes drug treatments for patients with a high risk of heart disease, due to the varying levels of cardiovascular risk associated with certain diabetes drugs, according to one researcher.…
A federal judge has been asked to enter summary judgement in failure to warn lawsuits filed over the pancreatic cancer risk with Byetta, Januvia, Janumet and Victoza, arguing that the FDA would have any proposed warning update.…
Some diabetes drugs unexpected linked to heart failure risks, new report finds.…
A new study failed to find links between Januvia and increased cardiovascular risks.…
A new study links blood glucose levels to an increased risk of pancreatic cancer.…